| scholarly article | Q13442814 |
| P50 | author | Richard Bucala | Q28321402 |
| Erol Fikrig | Q28355961 | ||
| Ruth R Montgomery | Q56373575 | ||
| Tian Wang | Q61159575 | ||
| Terrence Town | Q115617286 | ||
| P2093 | author name string | Lin Leng | |
| Alvaro Arjona | |||
| Susan J Wong | |||
| Courtney McDonald | |||
| Harald G Foellmer | |||
| P2860 | cites work | Epidemiology and transmission dynamics of West Nile virus disease | Q24603195 |
| Long-term prognosis for clinical West Nile virus infection | Q24603453 | ||
| Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival | Q27472671 | ||
| Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion | Q27477543 | ||
| The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents | Q27638947 | ||
| Macrophage migration inhibitory factor: a regulator of innate immunity | Q28204158 | ||
| Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease | Q28212726 | ||
| MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia | Q28265011 | ||
| Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response | Q28592426 | ||
| Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
| West Nile virus: a primer for the clinician | Q29620970 | ||
| Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction | Q33798564 | ||
| Inflammatory mediators and modulation of blood-brain barrier permeability | Q33851290 | ||
| Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites | Q33896841 | ||
| Role for macrophage migration inhibitory factor in asthma. | Q34063699 | ||
| Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium | Q34160505 | ||
| Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. | Q34681102 | ||
| Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance | Q34708975 | ||
| Migration inhibitory factor expression in experimentally induced endotoxemia | Q35765238 | ||
| West Nile virus: where are we now? | Q35874060 | ||
| Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria | Q36310840 | ||
| Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain | Q36348144 | ||
| The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor | Q36363184 | ||
| Immunopathology of flavivirus infections | Q36673924 | ||
| Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection | Q39684491 | ||
| West Nile: worldwide current situation in animals and humans | Q39688642 | ||
| Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. | Q40168090 | ||
| Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury | Q40307712 | ||
| West nile virus activity--United States, January 1-November 7, 2006. | Q40465214 | ||
| Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients | Q40488945 | ||
| IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection | Q40551940 | ||
| Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. | Q40596353 | ||
| The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression | Q41906396 | ||
| TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. | Q41941662 | ||
| Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. | Q41962820 | ||
| Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain | Q43001363 | ||
| Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor | Q43641028 | ||
| Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system | Q43684853 | ||
| HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain | Q44342231 | ||
| Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis | Q44648951 | ||
| Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis | Q44830790 | ||
| Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration | Q45733547 | ||
| Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes | Q46404265 | ||
| ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis | Q46663769 | ||
| Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis | Q48197421 | ||
| The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system | Q48377406 | ||
| IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program | Q48406766 | ||
| Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor | Q57317089 | ||
| Protection from septic shock by neutralization of macrophage migration inhibitory factor | Q64132865 | ||
| Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome | Q73122420 | ||
| A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis | Q74315912 | ||
| Human cytomegalovirus-mediated induction of MIF in fibroblasts | Q74587985 | ||
| Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha | Q77186204 | ||
| Macrophage migration inhibitory factor | Q81599822 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| macrophage | Q184204 | ||
| urban ecology | Q1430301 | ||
| P304 | page(s) | 3059-66 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion | |
| P478 | volume | 117 |
| Q27670700 | A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF) |
| Q33500775 | A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor |
| Q90440535 | A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity |
| Q35071632 | A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. |
| Q38950405 | Age-related alterations in immune responses to West Nile virus infection. |
| Q38866173 | An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection |
| Q56340954 | An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection |
| Q36418544 | Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis. |
| Q34553426 | Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae |
| Q38042932 | Brain miffed by macrophage migration inhibitory factor |
| Q37228462 | CD84 is a survival receptor for CLL cells |
| Q61805301 | CSF1R antagonism limits local restimulation of antiviral CD8 T cells during viral encephalitis |
| Q35583988 | Comparison of attenuated and virulent West Nile virus strains in human monocyte-derived dendritic cells as a model of initial human infection |
| Q34197622 | Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis |
| Q34840113 | Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes |
| Q36990515 | Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view |
| Q38002982 | D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q27486589 | Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis |
| Q39390167 | Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication. |
| Q35555139 | Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q33532590 | Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis |
| Q90798978 | Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis |
| Q38216286 | Flaviviruses are neurotropic, but how do they invade the CNS? |
| Q36770589 | Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis |
| Q36950014 | Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody |
| Q34406318 | IL-22 signaling contributes to West Nile encephalitis pathogenesis |
| Q33885597 | In Vitro and In Vivo Blood-Brain Barrier Models to Study West Nile Virus Pathogenesis |
| Q38156879 | Innate host responses to West Nile virus: Implications for central nervous system immunopathology |
| Q35382179 | Innate immune control of West Nile virus infection |
| Q59349883 | Intrathecal expression of IL-5 and humoral response in patients with tick-borne encephalitis |
| Q33945936 | Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke |
| Q38836537 | Lessons from the Murine Models of West Nile Virus Infection |
| Q27486985 | Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis |
| Q39340752 | MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics. |
| Q37189109 | MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation |
| Q27687233 | MIF: mood improving/inhibiting factor? |
| Q30499340 | Macrophage Migration Inhibitory Factor Promotes Cell Death and Aggravates Neurologic Deficits after Experimental Stroke |
| Q91776043 | Macrophage migration inhibitory factor enhances influenza-associated mortality in mice |
| Q37279929 | Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection |
| Q35837963 | Macrophage migration inhibitory factor in protozoan infections. |
| Q55024863 | Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation. |
| Q35967659 | Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis. |
| Q27025556 | Mechanism of West Nile virus neuroinvasion: a critical appraisal |
| Q34031442 | Mice with different susceptibility to Japanese encephalitis virus infection show selective neutralizing antibody response and myeloid cell infectivity |
| Q37956596 | Neuroinvasive flavivirus infections |
| Q41135035 | Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection |
| Q34603029 | Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice |
| Q35188179 | Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection |
| Q47285998 | Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning. |
| Q35007289 | Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor |
| Q37082586 | Risk factors for West Nile virus infection and disease in populations and individuals |
| Q27489829 | Role of two distinct γδ T cell subsets during West Nile virus infection |
| Q37955411 | Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe? |
| Q36393432 | Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signaling |
| Q43046594 | Southern California neuroinvasive West Nile virus case series |
| Q27684665 | Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment |
| Q37611829 | Targeting host factors to treat West Nile and dengue viral infections |
| Q35180790 | The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). |
| Q38710834 | The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis |
| Q54231425 | The intrathecal expression and pathogenetic role of Th17 cytokines and CXCR2-binding chemokines in tick-borne encephalitis. |
| Q38990641 | The non-mammalian MIF superfamily. |
| Q27487955 | The structural immunology of antibody protection against West Nile virus |
| Q33596925 | Transcellular transport of West Nile virus-like particles across human endothelial cells depends on residues 156 and 159 of envelope protein |
| Q27490259 | Tregs control the development of symptomatic West Nile virus infection in humans and mice |
| Q36812354 | Viral interactions with the blood-brain barrier: old dog, new tricks |
| Q34237824 | Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals |
| Q38351324 | Viral sensing at the blood-brain barrier: new roles for innate immunity at the CNS vasculature |
| Q26766121 | West Nile Virus Infection in the Central Nervous System |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q56932479 | West Nile virus |
| Q27488411 | West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier |
| Q33921481 | West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model |
| Q37127517 | West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases |
| Q30227143 | West nile virus: characteristics of an african virus adapting to the third millennium world. |
Search more.